Stock listing
NASDAQ:ANDS Anadys Pharmaceuticals Inc Stock
Follow Anadys Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ANDS
$3.70 USD
Close on Nov 23, 2011 · No longer trades
- Lowest – highest close
- $0.645 – $16.51 USDSince Mar 26, 2004 · lowest Sep 9, 2011 · highest Mar 30, 2006
Delisted NASDAQ:ANDS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ANDS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen T Worland Other companies: eFFECTOR Therapeutics Inc (Chief Executive Officer, Director · Aug 25, 2021 – May 15, 2024 · Past); GenMark Diagnostics Inc (Director · Jun 13, 2012 – May 29, 2014 · Past) | President and CEO, Director · Mar 2, 2006 – Dec 13, 2010 · Past |
| Steven H Holtzman Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Biogen Inc. (EVP Corporate Development · Jan 4, 2011 – Feb 23, 2016 · Past) | Director · Jun 2, 2006 – May 28, 2010 · Past |
| James L Freddo Other companies: InfuSystems Holdings, Inc. (Director · Apr 22, 2008 – Dec 3, 2010 · Past) | SVP, Drug Development and CMO, Director · Jul 10, 2006 – Jan 20, 2011 · Past |
| Jennifer K Crittenden | Vice President, Finance · Dec 8, 2006 – Dec 8, 2006 · Past |
| Kevin L Eastwood | SVP, Corporate Development · Jan 3, 2011 – Jan 20, 2011 · Past |
| Marios Fotiadis | Director · Jun 2, 2006 – May 27, 2011 · Past |
Log in to ask 6ix AI your own questions about Anadys Pharmaceuticals Inc.